Literature DB >> 3318370

Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics.

S H Kubo1, M Clark, J H Laragh, J S Borer, R J Cody.   

Abstract

To characterize further the pathophysiology of the neurohormonal vasoconstrictor pathways in congestive heart failure (CHF), plasma renin activity, plasma norepinephrine, blood pressure, blood volume and renal hemodynamics were measured in 12 patients with mild to moderate CHF. In addition, the response to the gravitational stress of head-up tilt and the influence of 3 weeks of furosemide treatment as stimuli of neurohormonal activity were assessed. Supine plasma renin activity before diuretics was relatively normal at 1.94 +/- 1.6 ng/ml/hr and was significantly increased to 3.9 +/- 2.7 ng/ml/hr after diuretics. During tilt, there was a significant reflex increase in plasma renin activity both before and after diuretics. Plasma norepinephrine was also relatively normal before diuretics (325 +/- 211 pg/ml), did not increase after diuretics, but showed significant increases during tilt both before and after diuretics. Diuretic administration led to decreases in both systolic and diastolic blood pressures, but there was no change in body weight or total blood volume. In addition, diuretic administration did not result in any significant changes of renal blood flow (546 +/- 119 to 634 +/- 204 ml/min/1.73m2), glomerular filtration rate (81 +/- 22 to 90 +/- 27 ml/min/1.73m2) or filtration fraction (0.26 to 0.25). The present study demonstrates that the renin-angiotensin system and the sympathetic nervous system were not activated in the early symptomatic stages of CHF and that baroreceptor stimulation of these pathways during head-up tilt was relatively preserved. Renin secretion increased during diuretic administration, suggesting that the macula densa signal for renin release was also preserved in patients with relatively mild CHF.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3318370     DOI: 10.1016/0002-9149(87)90615-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

Review 1.  Cardiorenal syndrome: still not a defined entity.

Authors:  Carlo Longhini; Christian Molino; Fabio Fabbian
Journal:  Clin Exp Nephrol       Date:  2010-02-20       Impact factor: 2.801

Review 2.  Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.

Authors:  Clyde W Yancy
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  Optimal use of diuretics in patients with heart failure.

Authors:  Jigar Patel; Michael Smith; J Thomas Heywood
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

Review 4.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 5.  Role of vasopressin antagonists in the management of acute decompensated heart failure.

Authors:  Cesare Orlandi; Christopher A Zimmer; Mihai Gheorghiade
Journal:  Curr Heart Fail Rep       Date:  2005-09

6.  Grading the severity of congestive heart failure in infants.

Authors:  R D Ross; R O Bollinger; W W Pinsky
Journal:  Pediatr Cardiol       Date:  1992-04       Impact factor: 1.655

7.  Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones.

Authors:  I S Anand; Y Chandrashekhar; R Ferrari; P A Poole-Wilson; P C Harris
Journal:  Br Heart J       Date:  1993-10

Review 8.  Physiological changes due to age. Implications for drug therapy of congestive heart failure.

Authors:  R J Cody
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

9.  Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure.

Authors:  H Schunkert; J R Ingelfinger; A T Hirsch; S S Tang; S E Litwin; C E Talsness; V J Dzau
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 10.  Post-myocardial infarction ventricular remodeling: animal and human studies.

Authors:  D E Vaughan; M A Pfeffer
Journal:  Cardiovasc Drugs Ther       Date:  1994-06       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.